Australian Scientists Identify a Never Before Seen Genetic Disease
According to a story from Science Daily, a group of scientists from the Australian National University have managed to discovery a new genetically linked disease
The Rare Genomes Project at the Broad Institute of MIT and Harvard is a non-profit, academic research institution that is utilizing genomic data in order to learn more about human health and disease. The Rare Genomes Project is a research study conducted through the Broad institute that is providing rare and undiagnosed families access to the latest advances in genome sequencing. Eligible families who consent to participate in the project provide a blood sample and discuss their experiences with their undiagnosed condition. The blood is used for DNA sequencing with the hopes of discovering a genetic variance causing the condition. The more families that participate, the more context researchers have about what variants may lead to what manifestations. The cumulative de-identified data from the project is made available to researchers worldwide to help as many people as possible reach a diagnosis and to advance research internationally.
Here is a list of conditions this partner raises awareness and advocacy for:
According to a story from Science Daily, a group of scientists from the Australian National University have managed to discovery a new genetically linked disease
Show of hands – who has ever indulged in a little beauty pampering? A mani/pedi? A haircut? A shave? Sure, that was a trick question
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
What best describes you when it comes to rare disease? (check all that apply)
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.